HTFL
HealthcareHeartflow, Inc. Common Stock · Medical - Healthcare Information Services · $3B
What is Heartflow, Inc. Common Stock?
HeartFlow is a medical technology company focused on non-invasive coronary artery disease diagnosis. Its AI-driven platform gives clinicians a detailed, personalized view of a patient's heart without invasive procedures.
HeartFlow's platform analyzes a standard coronary CT scan and uses artificial intelligence alongside computational fluid dynamics to generate a personalized 3D model of the heart. This model reveals blood flow patterns, arterial narrowing, and plaque characteristics — helping physicians make more informed treatment decisions without additional invasive testing.
Founded in 2007 and headquartered in Mountain View, California.
- HeartFlow Platform — AI-powered 3D cardiac modeling
- Non-invasive blood flow and stenosis analysis
- Plaque volume and composition assessment
Is HTFL a Good Stock to Buy?
UQS Score rates HTFL as Below Average overall.
Growth stands out as the strongest pillar, reflecting the expanding adoption of AI-driven cardiac diagnostics. The Risk pillar also rates favorably, suggesting the business carries a manageable risk profile relative to peers.
Quality rates Weak, pointing to underlying profitability challenges common in early-stage medtech. Valuation is Elevated, meaning the market may already be pricing in significant future growth.
See the exact pillar breakdown and full financial metrics by signing up for a Pro account. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does HTFL pay dividends?
No — Heartflow, Inc. Common Stock does not currently pay a dividend.
HTFL does not currently pay a dividend. As a growth-stage medical technology company, HeartFlow reinvests available capital into platform development and market expansion rather than returning cash to shareholders.
When does HTFL report earnings?
HeartFlow reports earnings on a quarterly cadence, typical for US-listed equities.
The company's Growth pillar rates Strong, suggesting revenue momentum is building as its platform gains clinical adoption. Profitability remains a work in progress, consistent with the Weak Quality rating.
For the most recent quarter's results, visit HeartFlow's investor relations page directly.
HTFL Price History
+1.1% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
Frequently Asked Questions
What does HeartFlow do?
HeartFlow develops an AI-powered platform that converts a standard coronary CT scan into a personalized 3D model of the heart. The platform analyzes blood flow, arterial narrowing, and plaque — giving physicians detailed diagnostic insights without invasive procedures.
Does HTFL pay dividends?
No, HTFL does not pay a dividend. HeartFlow is focused on growth and reinvests capital into expanding its platform and clinical reach rather than distributing cash to shareholders.
When does HTFL report earnings?
HeartFlow follows a standard quarterly earnings cadence. For confirmed dates and the latest results, check HeartFlow's official investor relations page.
Is HTFL a good stock to buy?
UQS Score rates HTFL as Below Average overall. Growth is a clear strength, but Weak Quality and Elevated Valuation are meaningful concerns. The complete pillar breakdown is available to Pro members at uqs-score.com.
Is HTFL overvalued?
The UQS Valuation pillar for HTFL is rated Elevated, suggesting the current market price reflects high expectations for future growth. Whether that premium is justified depends on execution — view the full analysis with a Pro account.
What is HTFL's market cap bracket?
HTFL is classified as a mid-cap stock, placing it in a range that typically reflects an established but still-growing business with meaningful upside and risk potential.
Is HTFL a long-term quality investment?
As a long-term quality indicator, UQS rates HTFL Below Average. Strong Growth is a positive signal, but sustained quality and profitability improvements would be needed to support a higher long-term rating. Pro members can track pillar changes over time.
What sector does HTFL belong to?
HeartFlow operates in the Healthcare sector, specifically within medical technology. Its focus on AI-assisted cardiac diagnostics places it at the intersection of digital health and cardiovascular care.
Unlock Full HTFL Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the exact UQS pillar scores across Quality, Growth, Moat, Risk, and Valuation
- ✓Access full financial metrics and sector comparisons
- ✓Track how HTFL's quality profile changes each quarter
- ✓Compare HTFL against peers in the Healthcare sector
Pro Analysis
HTFL — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | 42.6 | 32.5 | 42.0 | 66.2 | 71.9 | 0.0 | -3.4 |
| Apr 2, 2026 | 46.0 | 32.5 | 42.0 | 82.7 | 71.9 | 0.0 | — |
HTFL — Pillar Breakdown
Quality
— 32.5/100 (25%)Heartflow, Inc. Common Stock currently shows below-average quality metrics, suggesting challenges with profitability.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 80.0/100 (20%)Heartflow, Inc. Common Stock is growing rapidly with strong revenue and earnings expansion.
Revenue trajectory over the last twelve months.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Risk
— 82.4/100 (15%)Heartflow, Inc. Common Stock carries minimal financial risk with conservative leverage and strong solvency.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 0.0/100 (15%)Heartflow, Inc. Common Stock appears expensively valued relative to its fundamentals and growth prospects.
Moat
— 42/100 (25%)Heartflow, Inc. Common Stock possesses some competitive advantages but faces meaningful competition. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for HTFL.
Score Composition
Financial Data
More Stock Analysis
How is the HTFL UQS Score Calculated?
The UQS (Unified Quality Score) for Heartflow, Inc. Common Stock is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Heartflow, Inc. Common Stock's competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Heartflow, Inc. Common Stock is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.